Daniel Brennan is Executive Vice President and Chief Financial Officer for Boston Scientific Corporation and a member of its Executive Committee. In this role, he is responsible for several Company functions, including Global Controllership, Corporate Finance, Treasury, Corporate Tax, Corporate Analysis and Control, and Corporate New Business Development. Previously, he served as Senior Vice President and Corporate Controller. In this role, Brennan was responsible for the Global Controllership organization, including the Company’s accounting and financial planning processes. Brennan joined Boston Scientific in 1996 and has served in a number of financial roles of increasing responsibility, including Assistant Corporate Controller; Vice President-Worldwide Financial & Strategic Planning; Vice President-Investor Relations, Vice President-International Finance and Vice President-Finance & Information Technology for the company’s Cardiovascular Division. Prior to joining Boston Scientific, Brennan held several finance positions at Millipore Corporation and Standex Corporation. Brennan is a Certified Public Accountant and earned his B.S. in Finance and Investments and his M.B.A. from Babson College.